Opdivo (Nivolumab ) Patient Stories

Opdivo (nivolumab) Patient Stories

Opdivo, also known by the generic name, nivolumab, is a therapy meant to treat a variety of types of cancer, including skin cancer, Hodgkin lymphoma, and others. Unlike chemotherapy, Opdivo, and immunotherapies like it, work with your immune system to fight cancer cells.

Read on for Opdivo experiences from real cancer patients:

Kidney Cancer Stories: Renal Cell Carcinoma, Stage 4 | Laura’s Story

Laura F., Renal Cell Carcinoma (Clear Cell), Stage 4

1st Symptoms: Severe headaches

Treatment: Partial nefrectomy (surgical removal of one kidney), Gamma Knife brain radiation, stereotactic body radiation therapy (SBRT), nivolumab (Opdivo), Avastin, cabozantinib
Skin Cancer Stories: Melanoma, Stage 3A | Ellis’ Story

Ellis E., Melanoma, Stage 3A

Cancer details: Accounts for 1% of all skin cancers
1st Symptoms:
Changing mole on arm
Lymph node resection, immunotherapy (Opdivo), targeted therapy (BRAF inhibitor)
Hodgkin’s Lymphoma Stories: Classical, Stage 2B | Katee’s Patient Story

Katee P., Hodgkin, Stage 2B

Cancer details: Accidentally found in x-ray after months of symptoms
1st Symptoms: Night sweats, fatigue, extreme itchiness, persistent cough
Treatment: AAVD chemo, clinical trial w/brentuximab (Adcetris) + nivolumab (Opdivo) immunotherapy